NCT04656912

Brief Summary

Hyperbaric oxygen therapy (HBO2) is recommended for symptomatic patients within 24 h of carbon monoxide (CO) poisoning. However, previous major studies found significantly better outcomes with HBO2 in patients treated within 6 h. Currently, there is no consensus on a CO poisoning-to-HBO2 interval that would not be beneficial. Therefore, the investigators aimed to evaluate the difference in therapeutic effect depending on the poisoning-to-HBO2 interval after CO exposure in patients with acute CO poisoning who received HBO2 within 24 h. The investigators compared the neurocognitive outcomes of patients according to HBO2 time intervals based on the outcomes of patients treated within 6 h (control group) with propensity score matching using the CO poisoning registry of our hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
706

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 30, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 7, 2020

Completed
Last Updated

December 29, 2020

Status Verified

December 1, 2020

Enrollment Period

2 months

First QC Date

November 30, 2020

Last Update Submit

December 27, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Frequency of poor global deterioration scale (GDS) at 1 month after CO exposure in the overall matched cohort

    Frequency of poor GDS (4-7 scores) outcome at 1 month after CO exposure between early group and late group \*GDS (the minimum and maximum: 1-7, higher scores mean a worse outcome) Poor GDS outcome means from 4 to 7 in GDS score.

    At 1 month after CO exposure

  • Frequency of poor GDS at 6 months after CO exposure in the overall matched cohort

    Frequency of poor GDS outcome at 6 months after CO exposure between early group and late group

    At 6 months after CO exposure

Secondary Outcomes (12)

  • Frequency of poor GDS at 1 month after CO exposure between early group and case 1 group in the matched cohort

    At 1 month after CO exposure

  • Frequency of poor GDS at 1 month after CO exposure between early group and case 2 group in the matched cohort

    At 1 month after CO exposure

  • Frequency of poor GDS at 1 month after CO exposure between case 1 group and case 2 group in the matched cohort

    At 1 month after CO exposure

  • Frequency of poor GDS at 6 months after CO exposure between early group and case 1 group in the matched cohort

    At 6 months after CO exposure

  • Frequency of poor GDS at 6 months after CO exposure between early group and case 2 group in the matched cohort

    At 6 months after CO exposure

  • +7 more secondary outcomes

Study Arms (1)

Acute CO poisoning

A diagnosis of CO poisoning was made according to medical history and carboxyhemoglobin \>5% (\>10% in smokers).

Procedure: Hyperbaric oxygen therapy

Interventions

Patients with any symptoms and signs were treated with HBO2. During the first HBO2, initial compression was performed to 2.8 atmospheres absolute (ATA) for 45 min, followed by 2.0 ATA for 60 min. If an additional HBO2 was possible within 24 h, then 2.0 ATA was administered for 90 min. Moreover, if necessary, patients were treated with HBO2, even after 24 h, until all symptoms resolved.

Acute CO poisoning

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

CO poisoned patients

You may qualify if:

  • CO poisoned patients

You may not qualify if:

  • Not treated with HBO2
  • \< 16 years old
  • Non-acute CO poisoning
  • Received HBO2 more than 24 h after poisoning
  • A history of previous stroke or neurocognitive diseases
  • Did not undergo follow-up until 6 months
  • Received specific treatment other than HBO2, such as therapeutic hypothermia
  • A history of previous CO exposure
  • A serious illness that can affect the patient's prognosis such as advanced cancer
  • A cardiac arrest before ED arrival
  • No recorded data on important variables, such as time from CO exposure to the start of first HBO2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wonju Severance Christian Hospital

Wŏnju, Gangwon-do, 26426, South Korea

Location

Related Publications (1)

  • Lee Y, Cha YS, Kim SH, Kim H. Effect of Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning. Crit Care Med. 2021 Oct 1;49(10):e910-e919. doi: 10.1097/CCM.0000000000005112.

MeSH Terms

Conditions

Carbon Monoxide Poisoning

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Gas PoisoningPoisoningChemically-Induced Disorders

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 30, 2020

First Posted

December 7, 2020

Study Start

September 1, 2020

Primary Completion

October 30, 2020

Study Completion

October 30, 2020

Last Updated

December 29, 2020

Record last verified: 2020-12

Locations